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Background: Extremity fractures such as wrist and ankle fractures are a common and costly healthcare problem.
The management of these fractures depends on fracture type and loss of congruity of the joint, resulting in cast
immobilization or operative treatment. Loss of congruity or displacement leading to uneven joint loading, osteoarthritis
and an increased probability of a poor functional outcome should be identified within the first 2 weeks post-trauma,
based upon radiographs to determine optimal treatment. After this period, routine radiographs are scheduled for
monitoring the bone-healing process. Current protocols describe imaging at 1, 2, 6 and 12 weeks post-trauma.
However, it is questionable whether routine radiography following the initial follow-up ( 2-weeks post-trauma) is
cost effective.
The aim of this study is to determine whether a modification of the radiographic follow-up protocol can be conducted
with no worse outcome and less cost than the current standard of care for patients with a wrist or ankle fracture.
Methods/design: In a multicenter randomized controlled trial, 697 patients aged 18 years or older will be included:
385 wrist fracture- and 312 ankle fracture patients. Patients will be randomized into two groups: Group 1 receives usual
care, consisting of radiographs 1, 2, 6 and 12 weeks post-trauma; Group 2 receives radiographs beyond the initial
follow-up only when clinically indicated. The primary outcome is the overall extremity-specific function. For wrist
fractures, this includes the Disabilities of the Arm, Shoulder and Hand Score; for the ankle fractures, this includes the
Olerud and Molander ankle score. Secondary outcomes include: healthcare cost, the specific function measured with
the Patient Rated Wrist and Hand Evaluation for wrist fractures and American Academy of Orthopaedic Surgeons foot
and ankle questionnaire for ankle fractures, pain-intensity, health-related quality of life, self-perceived recovery, and
complications. Both groups will be monitored at 1, 2, and 6 weeks and 3, 6, and 12 months.
Discussion: This study will provide data on (cost) effectiveness of routine radiography in the follow-up of wrist and
ankle fractures, and could pave the way for a change in (inter)national protocols.
Trial registration: Netherlands Trial Register NTR4610, registration date 22 June 2014.
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Extremity fractures are a common and costly healthcare
problem affecting all age groups [1]. In the adult popula-
tion, the incidence of fractures to the wrist (distal radius)
and ankle (malleolar fractures) in the Netherlands is about
20,000 and 15,000 per year, respectively [2]. These are the
most common fractures encountered, accounting for
about 18% and 10% of all fractures, respectively. Treat-
ment of fractures consists of either immobilization or sur-
gical fixation (18% of distal radius fractures and 35% of
ankle fractures) [3]. The decision to operate should prefer-
ably be established within the first 2 weeks, as after this
period the bone healing has advanced to a stage in which
surgical treatment is more difficult. Loss of congruity or
(secondary) displacement can lead to uneven joint loading,
osteoarthritis and a poor outcome [4]. Resolution of soft-
tissue swelling and poor cast application leaves patients at
increased risk of fracture displacement [5]. This risk
makes early identification of the loss of congruity or
(secondary) displacement paramount. Displacement can
be identified within the first 2 weeks based upon radio-
graphic imaging. After this period, regular radiographs
and clinical assessment are frequently scheduled, based
upon existing local trauma protocols for monitoring the
fracture-healing process and clinical outcomes ([6,7]
and web-based protocols listed at the end of the article).
Current follow-up protocols
Current protocols that are used both nationally and
internationally recommend radiographic assessment at
all routine visits (that is, 1, 2, 6 and 12 weeks post-
trauma) in order to monitor fracture healing in fractures
of the distal radius and ankle. However, it is question-
able whether routine imaging following the initial
follow-up (that is, post 2-weeks) is justified [8]. Justifica-
tion for obtaining radiographs beyond the initial follow-
up includes documentation of splint application, resident
education, assurance that the fracture has not displaced,
and medico-legal protection against claims of unin-
tended harm [8]. Three retrospective studies have sug-
gested that routine radiography performed beyond the
2-week follow-up results in longer waiting room visits, un-
necessary radiation exposure and increased healthcare
costs without providing additional clinical information
that impacts clinical decision-making [8-10]. Thus, there
is evidence from multiple sources that routine radio-
graphic imaging beyond the 2-week period is clinically re-
dundant. Hence, the current protocol would not appear to
be cost effective. In The Netherlands, about 35,000
adults present yearly with fractures of the distal radius
and ankle. Based upon the current costs of imaging
[11], it is estimated that in the Netherlands approxi-
mately €2.9 million could be saved yearly by modifying
the current imaging protocol.Rationale
We hypothesize that a modification of the current radio-
graphic follow-up protocol towards a protocol with
fewer radiographs for patients with distal radius or ankle
fractures will lead to significant cost savings without
compromising quality of care. The aim of this study is to
determine whether a modification of the radiographic
follow-up protocol (no standard routine radiographs after
2-week initial follow-up) can be conducted for less direct
and indirect healthcare costs, but with no worse outcomes
than the current standard of care prescribed for patients
with distal radius or ankle fractures.Methods/design
Study design
The WARRIOR-trial (Wrist and Ankle fractures Routine
RadIOgraphy Reduction) is a multicenter randomized con-
trolled trial using a non-inferiority design.
The trial includes two study populations: distal radius
fracture patients and ankle fracture patients. The inter-
ventional effects will be analyzed separately for each type
of fracture as independent studies. The same design and
research questions apply for both studies.
The study will be conducted in three academic
hospitals in The Netherlands (Leiden University Med-
ical Center (LUMC), VU University Medical Center
Amsterdam (VUmc) and University Medical Center
Groningen(UMCG)). This study is approved by the
Medical Ethics Committee LUMC for all participating
centers (Number P14.086). The trial is registered in the
Dutch Trial Register (Nederlands Trial Register NTR4610,
registration date 22 June 2014). Study results will be
reported following the Consolidation of Standards of
Reporting Trials guidelines [12,13].Study population
All patients presenting to the emergency department
with a distal radius or ankle fracture and meeting the fol-
lowing criteria are eligible for inclusion: men or women
aged 18 years or older; fracture of the distal radius (Ortho-
paedic Trauma Association Committee for Coding and
Classification classification type A-C [14]) or fracture of the
ankle (Lauge-Hansen classification: supination-adduction
stage II, supination-external rotation stage II-IV, pronation-
external rotation stage I-IV [15]); sufficient understanding
of the Dutch language in order to independently complete
the follow-up questionnaires; written informed consent
provided by the patient.
Patients meeting one or more of the following criteria
will be excluded: pathological fractures; complicated frac-
tures (Gustilo grade 2 and 3); multi-extremity fractures;
psychiatric conditions; unable to complete follow-up (for
example, patients living abroad, incarcerated subjects).
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The inclusion and exclusion criteria will be checked for
all patients presenting with distal radius or ankle frac-
tures in the emergency department of the participating
centers. Eligible patients will be informed of the aims and
design of the study and will receive written information.
At the subsequent visit (that is, within the first 2 weeks
after the initial visit) the local investigator or research
nurse will check the inclusion and exclusion criteria
once more, provide additional information, answer any
questions regarding the study and obtain written informed
consent.
Randomization
Randomization of patients will be carried out after
obtaining written informed consent using an online
randomization program (ProMISe, www.clinicalresearch.
nl). Randomization will be stratified by center, type of frac-
ture (distal radius or ankle) and treatment (conservative
or surgical). Patients will be randomized into the following
two groups.
Group 1 – usual care
Group 1 will receive usual care according to the current
national protocol, indicating clinical follow-up as well as
radiographic evaluations in the outpatient clinic at 1, 2,
6, and 12 weeks after trauma.
Group 2 – reduced imaging
Group 2 will receive the same clinical evaluations as the
usual care group; however, no routine radiographs will
be performed beyond the initial 2 weeks. Radiography
during follow-up beyond the initial 2 weeks will beTable 1 Flowsheet
ER Week 1







Function scores (OMAS/AAOS or DASH/PRWHE)
Quality of Life (SF-36/EQ5D)
Self-perceived recovery
Direct and indirect healthcare costs
ROM
Complications X*
*Standard Protocol first 2 weeks. X, Measurement collected at each time point; ○, ra
Orthopaedic Surgeons; DASH, Disabilities of the Arm, Shoulder and Hand Score; EQ
PRWHE, Patient-Rated Wrist and Hand Evaluation; ROM, range of motion; SF-36, Shoallowed if any of the following are present: new trauma
to the distal radius or ankle; pain score >6 on the 11-
point visual analogue scale (VAS); loss of range of mo-
tion (ROM); neurovascular symptoms; at the discretion
of the clinician, in which case the indication for radiog-
raphy is to be recorded in the medical records.
Aftercare apart from radiology will be identical for
both study groups and according to the local standards.
At 6 and 12 weeks, 6 months and 1 year, patients will
be requested to fill out the questionnaires. The patient
can chose between a paper version or a web-based ver-
sion of the questionnaire. Reminders will be sent when
necessary, and attempts will be made to track drop-outs
if possible. An overview of follow-up and measurements
is provided in Table 1.
Subjects can leave the study at any time for any reason
if they wish to do so without any consequences; patients
randomized to Group 2 will revert to the usual care, the




The primary outcome is the overall extremity-specific
functional status, which for both types of fracture will
be measured using Dutch versions of the following
questionnaires.
For distal radius fractures the Disabilities of the Arm,
Shoulder and Hand Score (DASH) will be used. DASH
is the most commonly used questionnaire for measuring
upper extremity function [16]. It is a 30-item question-
naire that was designed to evaluate symptoms and phys-
ical function in patients with upper extremity disorders.Week 2 Week 6 Week 12 Week 26 Week 52
X
X
X* X X ○ ○
X* ○ ○ ○ ○
X X X X X
X X X X X
X X X X X
X X X X
X X X X
X X
X* X X X X
diography only when clinically indicated; AAOS, American Academy of
5D, EuroQol-5D; ER, emergency room; OMAS, Olerud and Molander Ankle Score;
rt form-36.
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of the responses. This number is then divided by 1.2 to
obtain the score. Missing items are replaced by the mean
value of the responses before summing. Scores range from
0 to 100, with 0 reflecting no pain/disability [16-18]. The
overall score cannot be calculated if three items or more
are missing [16,17,19].
For ankle fractures the Olerud and Molander Ankle
Score (OMAS) will be used. The OMAS is a nine-item
questionnaire evaluating the functional outcome of the
ankle after injury. Scores range from 0 to 100, with 100
reflecting no pain/disability [20].
Secondary outcome measures are: costs; specific func-
tion measured with the Patient-Rated Wrist and Hand
Evaluation (PRWHE) for the wrist fractures and the
American Academy of Orthopaedic Surgeons (AAOS)
foot and ankle questionnaire for ankle fractures; pain in-
tensity at rest; health-related quality of life measured
with the Short Form-36 (SF-36) questionnaire and the
EuroQol-5D (EQ5D) questionnaire; self-perceived recov-
ery; ROM; and complications.
Costs will be investigated using a healthcare utilization
questionnaire. The costs of healthcare consumption in-
clude, for example, costs for consulting the general prac-
titioner, company doctor and/or physiotherapist, costs of
medication and hospitalization, and costs of absence
from work associated with the fracture of the distal ra-
dius or ankle.
The PRWHE is a 15-item (five pain and 10 disability
items) questionnaire that rates pain and disability of the
wrist in functional activities [18]. Scoring is done by
adding up the sum of the five pain items and the sum of
the 10 disability items, and dividing by two. Missing
items are replaced by the mean score of the subscale.
Scores range from 0 to 100, with 0 reflecting no pain/
disability [16-18].
The AAOS foot and ankle questionnaire is a commonly
used 25-item questionnaire that combines items on pain,
function, stiffness and swelling, and allows assessment of
the patient’s perception of the condition of the ankle/foot
and the treatment progress [21,22]. Scoring is done by an
online worksheet that can be found at http://www.aaos.
org/research/outcomes/outcomes_lower.asp.
Pain intensity at rest is measured using a continues
VAS, where 0 reflects no pain and 10 the worst possible
pain.
The SF-36 is a 36-item questionnaire about health status
recorded by the patient. The items are subdivided into
eight health concepts. Combining these concepts leads to
two health scales: a physical health scale and a mental
health scale [23,24]. The scores range from 0 to 100
points, with higher scores reflecting better function. The
derived score has to be converted to a norm-based score
in order to make it possible to compare the score with thenorms for the general population of the United States
(1998), in which each scale was scored to have the same
average of 50 points and the same standard deviation of
10 points [25,26].
The EQ5D is a five-item questionnaire to assess health-
related quality of life. The questionnaire measures the
ability to walk, the ability to perform daily activities, de-
pression, anxiety and pain on a three-point scale. These
scores are combined to describe the health status of
the patient, which can be linked to a preference (util-
ity) for the health status obtained from the general
population [27,28].
The self-perceived recovery is measured on a five-
point Likert-scale.
The ROM of the wrist or ankle joint will be measured
during the outpatient clinic visits at weeks 6 and 12 after
trauma. The ROM in the wrist will be tested by measuring
the palmar flexion, dorsal extension, pronation and supin-
ation. The ROM in the ankle will be tested by measuring
the flexion, plantar flexion, inversion and eversion.
Complications that will be registered include infection,
nonunion, malunion and implant failure. These will be
recorded from the medical charts by the investigator.
Potentially confounding variables, such as age, gender
and socio-demographic characteristics will be registered.Sample size calculation
For both types of fractures (distal radius and ankle), the
sample size was determined separately for both patient
groups. Based upon a margin of non-inferiority, which is
often the smallest value with a clinically important effect
[29], of 9 points on the DASH and OMAS (which is based
upon what is assumed to be clinically significant [30]) and
a standard deviation of 14 [31] and 20 [32], respectively,
70 distal radius and 142 ankle fractures are necessary to
demonstrate non-inferiority (power 0.85, alpha 0.05).
To enable a sensitivity analysis for evaluating the study
outcomes for two relevant subgroups (that is, conserva-
tively and surgically treated patients), more patients are
needed. Based on the empirical treatment ratio for con-
servative:surgical of 8:2 for distal radius fractures and 5:5
for ankle fractures, we calculated that 142/0.5 = 284 pa-
tients with ankle fractures and 70/0.2 = 350 patients with
distal radius fractures will need to be included. Account-
ing for a 10% loss to follow-up means 312 patients with
an ankle fracture and 385 patients with a distal radius
fracture are to be recruited.Statistical analysis
Data will be analyzed using the IBM SPSS version 20 or
higher (Armonk, NY: IBM Corp.). Characteristics of the
patients in the treatment groups will be presented using
descriptive statistics (mean ± standard deviation, median
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obtained after randomization.
The data analysis will be conducted according to the
intention-to-treat principle, with a normal approxima-
tion for all questionnaires at 6, 12, 26 and 52 weeks for
both types of fractures. For analysis of the primary study
outcome, linear and generalized multilevel analyses will
be used accounting for dependency within hospitals, cli-
nicians and patients over time (four-level model). This
means, among other things, that the data are to be ana-
lyzed longitudinally and, thus, the follow-up measure-
ments are to be incorporated in the analyses. Results will
be expressed as confidence intervals and these will be sub-
sequently compared to the margin of non-inferiority in
order to make inferences about the non-inferiority of the
new intervention strategy. In addition to crude analyses,
all analyses will also be adjusted for pre-defined prognostic
factors, such as age, gender and fracture type. In a second-
ary analysis, a per-protocol analysis will be conducted
which will account for ‘contamination’, meaning those
randomized to the intervention group but nonetheless
requiring follow-up imaging not allowed in the original
treatment design (because there was a clinical indication
for imaging).
The secondary clinical outcome measures of quality of
life and pain will be analyzed in the same way as the
primary outcome measure. The secondary outcome
measures of ROM and complications will be compared
between the ‘usual care’ group and the ‘reduced images’
group over time.
The cost questionnaires will be used to perform an
economic evaluation, which will be conducted from a
societal perspective alongside the randomized controlled
trial. The aim of the economic evaluation is to measure,
value and analyze total costs of patients with distal ra-
dius and ankle fractures and to relate the difference in
costs to the difference in effects between the interven-
tion group which will receive only the initial follow-up
radiographs (at 1 and 2 weeks) and the comparison (that
is, usual care) which will receive imaging at the initial
follow-up plus at 6 and 12 weeks. Both cost-effectiveness
and cost-utility analysis will be performed. The time
horizon of the economic evaluation is 12 months. Sensi-
tivity analyses will be performed to assess the robustness
of the results using different assumptions regarding costs
and effects.
The underlying assumption surrounding missing data
for this study is that the data are missing at random.
Therefore, given the mixed model approach for the
longitudinal analyses, missing data will not be imputed;
however, we will correct for baseline covariates thought
to be associated with the outcome, such as age, gender,
and variables related to the condition (for example, frac-
ture type), as well as variables thought to be related tomissingness. In a sensitivity analysis, complete data sets
will be compared to incomplete data sets in order to de-
termine how robust these findings are.Ethical considerations
The study design is in accordance with the Declaration
of Helsinki, version Fortaleza (Brazil), October 2013 [33],
and in accordance with the Dutch Medical Research In-
volving Human Subjects Act. Patients will not experience
any benefit from participating in the study. No risk is in-
volved for the group receiving usual care (Group 1). In
Group 2 without standard radiographs after 2 weeks, the
risk is considered minimal because radiographs will be
made when clinically indicated.
This study is approved by the medical research ethics
committee for all participating centers. The Medical Ethics
Committee LUMC acts as central ethics committee for
this trial (Number P14.086). An insurance which is in ac-
cordance with the legal requirements in the Netherlands
(Article 7 WMO and the Measure regarding Compulsory
Insurance for Clinical Research in Humans of 23 June
2003) has been obtained. This insurance provides cover
for damage to research subjects through injury or death
caused by the study. Once a year, information will be pro-
vided to the medical research ethics committee on the
numbers of subjects included and numbers of subjects
that have completed the trial, serious adverse events/ser-
ious adverse reactions, and other problems.Discussion
The current distal radius and ankle fracture protocols
recommend radiographic assessment at all routine visits.
It is questionable whether routine imaging following the
initial follow-up (that is, after 2 weeks), after which
definitive treatment is established (being surgical or
conservative), is justified [8]. Three retrospective studies
have suggested that radiographs performed beyond the
2-week follow-up result in longer waiting room visits,
unnecessary radiation exposure and increased healthcare
costs without providing additional clinical information
which impacts clinical decision-making [8-10]. Along-
side the clinical question about the justification of the
radiographs after the initial follow-up period, a cost-
effectiveness analysis is indicated as the current protocols
appear not to be cost effective. A randomized controlled
trial is needed to investigate whether a reduced imaging
protocol can be conducted for less cost, but with no worse
outcome than the current standard of care in those with
distal radius and ankle fractures. This study will provide
necessary data on (cost) effectiveness of routine radiog-
raphy in the follow-up of distal radius and ankle frac-
tures and could pave the way for a change in (inter)
national protocols.
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AAOS: American Academy of Orthopaedic Surgeons; DASH: Disabilities of the
Arm, Shoulder and Hand Score; EQ5D: EuroQol-5D; LUMC: Leiden University
Medical Center; OMAS: Olerud and Molander Ankle Score; PRWHE: Patient-
Rated Wrist and Hand Evaluation; ROM: Range of motion; SF-36: Short
Form-36; UMCG: University Medical Center Groningen; VAS: Visual analogue
scale; Vumc: VU University Medical Center; WARRIOR: Wrist and Ankle
fractures Routine RadIOgraphy Reduction.
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